Discover our tumor models in oncology for drug discovery programs
Oncodesign Services offers a range of discovery & preclinical services built upon a tumor models of syngeneic, orthotopic, cell-derived xenograft (CDX) and patient-derived xenograft (PDX) tumors.
Over 500 syngeneic, CDX and PDX tumor models are established in-house, covering 20 organ origins and up to 35 pathologies: bladder, blood, brain, breast, cervix, colon, head and neck, kidney, liver, lung, skin (melanoma), muscle, osteosarcoma, ovary, pancreas, prostate, Schwann cell, stomach and more. These cover solid tumors, hematological malignancies and metastasis models.
Tumors are used for in vivo modeling, in vitro screening and for target expression analysis. The tumors are stored as viable frozen stocks for propagation and often in FFPE blocks for ex vivo analysis of the TME. Please ask for slide samples.
Examples of tumor models
-
Popular Human CDX Models
Breast BT-474 | MDA-MB-231 | MX-1 | MDA-MB-468 | MCF-7 Brain U87MG Blood MV4.11 | Raji | Ramos | K-562 | Karpas-299 Colon HCT-116 | Ls174T |COLO-205 | HT-29 | LoVo Kidney BB64-RCC | A-498 Liver Hep3B | HepG2 | SK-HEP-1 Lung NCI-H460 | NCI-H1975 | Calu-6 | A-549 Ovarian NIH.OVCAR3 | A2780 | SK-OV-3 | PA-1 Prostate PC3 | LnCap.C4.2 | PC-3 | 22rv1 | MDA-PCa-2b Pancreas As-PC1 | BxPC3 Skin/Melanoma A375 | CMEL-5 | A-431 Stomach/Gastric AGS | Hs 746T -
Well Characterized Mouse Syngeneic Models
Bladder MBT-2 Breast EMT6 | 4T1 (Mets to lung) Colon C26 | C38 | MC38 | CT26 (Mets to lung) Kidney renca (mets to lung) Melanoma B16F10 (Mets to lung) Mesothelioma AB12 Liver Hepa 1-6 Lung LLc1 (Mets to lung) Pancreas Pan02 Lymphoma A20 Plasmacytoma MPC-11 Osteosarcoma NCTC-2472 (Mets) 
-
Patient-Derived Xenografts (PDX)
Oncodesign has collected PDX tumors for over 25 years, in partnership with the IMODI consortium. Currently, we have >200 unique tumors, covering 19 indications. These tumors have been characterized in regard to:
- Histology
- Conservation of phenotype and genotype
- Gene expression stability
- Gene mutation status
- Response to standard of care (SOC)
If the model you need requires a specific gene expression or gene mutation, please ask us to query the transcriptome. Many tumors are available as tissue microarray slides, cut from FFPE blocks.
- Rat Models
All syngeneic and CDX tumors are also available for in vitro, cell-based assays.
Read about Oncodesign Services’ in vitro biology here.
CASE STUDY with tumor model :
The U-87-MG brain glioblastoma CDX was used as a SC model in rats for a study of sorafenib and temozolomide. Negative control animals had exponential tumor growth after about 30 days. Sorafenib delayed the tumor growth and temozolomide completely attenuated the tumor growth in this model.
A request about our tumor models ? Contact-us !